Albers Jeffrey W.
20 Form 4 · free tier: 48h delay
Recent Form 4 slice from EDGAR — up to 30 filings (not a full archive).
For informational purposes only. Not investment advice. Data is aggregated from public SEC and congressional disclosures. Nothing on this site is a recommendation to buy or sell any security. Public disclosure of a trade is not evidence of wrongdoing or insider trading.
Recent Form 4 trades
Open-market purchases and sales
Spyre Therapeutics, Inc.
SYRE · Trade · Aug 7, 2026 · Filed · Aug 10, 2026 · filed 3 days after trade
$2,404,190
23,000 sh · 3 tx
Kymera Therapeutics, Inc.
KYMR · Trade · Dec 8, 2025 · Filed · Dec 8, 2025
$448,823
5,000 sh · 2 tx
Kymera Therapeutics, Inc.
KYMR · Trade · Oct 13, 2025 · Filed · Oct 14, 2025
$295,949
5,000 sh
Kymera Therapeutics, Inc.
KYMR · Trade · Jun 3, 2025 · Filed · Jun 3, 2025
$311,101
6,349 sh
Blueprint Medicines Corp
BPMC · Trade · May 27, 2025 · Filed · May 29, 2025 · filed 2 days after trade
$505,692
5,000 sh · 2 tx
Blueprint Medicines Corp
BPMC · Trade · Mar 12, 2025 · Filed · Mar 14, 2025 · filed 2 days after trade
$658,500
7,500 sh · 2 tx
Blueprint Medicines Corp
BPMC · Trade · Mar 5, 2025 · Filed · Mar 17, 2025 · filed 12 days after trade
$512,021
5,766 sh
Blueprint Medicines Corp
BPMC · Trade · Jan 21, 2025 · Filed · Jan 23, 2025 · filed 2 days after trade
$1,660,511
15,161 sh · 3 tx
Blueprint Medicines Corp
BPMC · Trade · Jan 13, 2025 · Filed · Jan 15, 2025 · filed 2 days after trade
$511,400
5,000 sh
Blueprint Medicines Corp
BPMC · Trade · Nov 7, 2024 · Filed · Nov 12, 2024 · filed 5 days after trade
$510,000
5,000 sh
Spyre Therapeutics, Inc.
SYRE · Trade · Oct 25, 2024 · Filed · Oct 28, 2024 · filed 3 days after trade
$10,929
300 sh
Blueprint Medicines Corp
BPMC · Trade · Sep 9, 2024 · Filed · Sep 11, 2024 · filed 2 days after trade
$1,685,891
19,702 sh · 2 tx